LifeVantage (NASDAQ:LFVN) Now Covered by Lake Street Capital

Lake Street Capital began coverage on shares of LifeVantage (NASDAQ:LFVN) in a research note published on Thursday morning, MarketBeat Ratings reports. The brokerage issued a buy rating and a $26.00 price objective on the stock.

LifeVantage Stock Down 1.6 %

Shares of NASDAQ LFVN traded down $0.29 during midday trading on Thursday, hitting $17.44. The stock had a trading volume of 15,388 shares, compared to its average volume of 64,605. The company has a market capitalization of $218.44 million, a price-to-earnings ratio of 54.50 and a beta of 0.87. LifeVantage has a 1-year low of $5.22 and a 1-year high of $18.41. The company has a fifty day moving average price of $13.88 and a 200 day moving average price of $10.24.

LifeVantage (NASDAQ:LFVN) last released its quarterly earnings results on Tuesday, October 29th. The company reported $0.15 EPS for the quarter, hitting the consensus estimate of $0.15. LifeVantage had a return on equity of 29.24% and a net margin of 2.11%. The firm had revenue of $47.21 million for the quarter.

LifeVantage Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, December 16th. Investors of record on Monday, December 2nd were paid a dividend of $0.04 per share. The ex-dividend date was Monday, December 2nd. This represents a $0.16 dividend on an annualized basis and a yield of 0.92%. LifeVantage’s payout ratio is currently 50.00%.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. Hantz Financial Services Inc. purchased a new stake in shares of LifeVantage during the second quarter valued at $91,000. Renaissance Technologies LLC boosted its stake in LifeVantage by 2.1% during the 2nd quarter. Renaissance Technologies LLC now owns 855,118 shares of the company’s stock valued at $5,490,000 after purchasing an additional 17,300 shares during the period. Ritholtz Wealth Management boosted its stake in LifeVantage by 62.0% during the 3rd quarter. Ritholtz Wealth Management now owns 28,666 shares of the company’s stock valued at $346,000 after purchasing an additional 10,974 shares during the period. Capital Management Corp VA bought a new stake in shares of LifeVantage in the 3rd quarter worth approximately $5,073,000. Finally, HighTower Advisors LLC bought a new stake in shares of LifeVantage in the 3rd quarter worth approximately $638,000. Institutional investors and hedge funds own 35.32% of the company’s stock.

LifeVantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.